9996 Stock Overview
Peijia Medical Limited engages in the research and development of transcatheter valve therapeutic and neuro interventional procedural medical devices.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 9996 from our risk checks.
Peijia Medical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$3.66 |
| 52 Week High | HK$10.42 |
| 52 Week Low | HK$3.54 |
| Beta | 0.47 |
| 1 Month Change | -20.26% |
| 3 Month Change | -30.81% |
| 1 Year Change | -64.12% |
| 3 Year Change | -87.84% |
| 5 Year Change | n/a |
| Change since IPO | -85.81% |
Recent News & Updates
More Unpleasant Surprises Could Be In Store For Peijia Medical Limited's (HKG:9996) Shares After Tumbling 27%
Mar 28
More Unpleasant Surprises Could Be In Store For Peijia Medical Limited's (HKG:9996) Shares After Tumbling 29%
Jan 22Recent updates
More Unpleasant Surprises Could Be In Store For Peijia Medical Limited's (HKG:9996) Shares After Tumbling 27%
Mar 28More Unpleasant Surprises Could Be In Store For Peijia Medical Limited's (HKG:9996) Shares After Tumbling 29%
Jan 22Estimating The Intrinsic Value Of Peijia Medical Limited (HKG:9996)
Dec 05Does Peijia Medical (HKG:9996) Have A Healthy Balance Sheet?
Oct 22Calculating The Fair Value Of Peijia Medical Limited (HKG:9996)
Aug 04Is Peijia Medical (HKG:9996) A Risky Investment?
May 29Getting In Cheap On Peijia Medical Limited (HKG:9996) Is Unlikely
May 10Are Investors Undervaluing Peijia Medical Limited (HKG:9996) By 40%?
Jan 17Despite Lacking Profits Peijia Medical (HKG:9996) Seems To Be On Top Of Its Debt
Oct 05A Look At The Fair Value Of Peijia Medical Limited (HKG:9996)
Aug 29We're Hopeful That Peijia Medical (HKG:9996) Will Use Its Cash Wisely
Mar 16We Think Peijia Medical (HKG:9996) Can Easily Afford To Drive Business Growth
Nov 26We're Hopeful That Peijia Medical (HKG:9996) Will Use Its Cash Wisely
Jul 30Is Peijia Medical Limited (HKG:9996) Worth HK$28.3 Based On Its Intrinsic Value?
May 05Could The Peijia Medical Limited (HKG:9996) Ownership Structure Tell Us Something Useful?
Mar 03Peijia Medical Limited's (HKG:9996) Intrinsic Value Is Potentially 43% Above Its Share Price
Jan 27
We Think Peijia Medical (HKG:9996) Can Afford To Drive Business Growth
Dec 23Shareholder Returns
| 9996 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | 0% | -2.3% | -2.0% |
| 1Y | -64.1% | -52.7% | -14.3% |
Return vs Industry: 9996 underperformed the Hong Kong Medical Equipment industry which returned -52.7% over the past year.
Return vs Market: 9996 underperformed the Hong Kong Market which returned -14.3% over the past year.
Price Volatility
| 9996 volatility | |
|---|---|
| 9996 Average Weekly Movement | 9.0% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in HK Market | 14.9% |
| 10% least volatile stocks in HK Market | 3.8% |
Stable Share Price: 9996's share price has been volatile over the past 3 months.
Volatility Over Time: 9996's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 1,040 | Yi Zhang | www.peijiamedical.com |
Peijia Medical Limited engages in the research and development of transcatheter valve therapeutic and neuro interventional procedural medical devices. Its transcatheter valve therapeutic products include TaurusOne, a transcatheter aortic valve replacement (TAVR) system; TaurusElite, a retrievable TAVR system; TaurusNXT, a non-glutaraldehyde crosslinking dry-tissue TAVR system; TaurusWave, a lithotripsy valvuloplasty system; TaurusApex, a polymeric leaflet TAVR system; Trilogy, a TAVR System; HighLife, a transseptal mitral value replacement system; Sutra, a TMV coaptation augmentation system; GeminiOne, a transcatheter edge-to-edge repair system; MonarQ and Peijia, which are transcatheter tricuspid valve replacement systems; TaurusAtlas, a transfemoral ballon catheter; TaurusExplora, a pre-shaped guidewire; and TaurusNavi, an introducer sheath. The company also offers Jasper and Presgo, that are detachable coils; Jasper SS detachable coil; intracranial adjunctive stents; SacSpeed, a balloon dilatation catheter; Tethys AS, an aspiration catheter; Syphonet, a stent retriever; Fastunnel, a balloon microcatheter; Fluxcap, a balloon guiding catheter; NeuroStellar, an intracranial stent; Presgo microcatheter and micro guidewire; Heralder guiding catheter and distal access catheter; Tethys, an intermediate catheter; and Jasper power supply.
Peijia Medical Limited Fundamentals Summary
| 9996 fundamental statistics | |
|---|---|
| Market cap | HK$2.47b |
| Earnings (TTM) | -HK$424.71m |
| Revenue (TTM) | HK$477.29m |
5.2x
P/S Ratio-5.8x
P/E RatioIs 9996 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9996 income statement (TTM) | |
|---|---|
| Revenue | CN¥441.13m |
| Cost of Revenue | CN¥115.76m |
| Gross Profit | CN¥325.37m |
| Other Expenses | CN¥717.90m |
| Earnings | -CN¥392.52m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.58 |
| Gross Margin | 73.76% |
| Net Profit Margin | -88.98% |
| Debt/Equity Ratio | 9.6% |
How did 9996 perform over the long term?
See historical performance and comparison